Dystrophinopathy

Sponsored diagnostic testing programs for Dystrophinopathy

Dystrophinopathy refers to a group of genetic muscle disorders caused by pathogenic variants in the DMD gene, leading to progressive muscle weakness. The spectrum includes Duchenne and Becker muscular dystrophies, which vary in severity and age of onset. Symptoms often involve difficulty walking, rising, or climbing stairs, with potential cardiac and respiratory involvement as the condition progresses.

1 program found for Dystrophinopathy

Programs

1 program
Invitae Unlock™

Invitae Arrhythmia and Cardiomyopathy Comprehensive Panel

The Invitae Unlock™ Cardiomyopathy & Arrhythmia program offers sponsored genetic testing for U.S. patients with suspected inherited cardiomyopathy or arrhythmia. The comprehensive panel supports diagnostic clarification, risk assessment, and family variant identification. The test is billed to insurance first; when a claim is denied or the patient is uninsured, the program's sponsor covers the cost of testing. Testing must be ordered by a qualified healthcare provider.

Cardiology
ViewOrder
Performing lab
Invitae | Labcorp